Delivery Order SPE2DB20D2104-SPE2DB25FLZYC
- Not listed
- This federal contract award, valued at $22,036.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Skyrizi 150 mg/ml pens, a medication used in the treatment of various medical conditions. The contract is a Firm Fixed Price Delivery Order with a completion date of March 25, 2025. The contract does not have a set-aside designation, indicating it was competed...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier, for the delivery of Skyrizi 150 mg/ml prefilled pens. The award, valued at $25,675.87, is a Firm Fixed Price Delivery Order contract with a completion date of June 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,316.28, is for the supply of Skyrizi 150 mg/mL prefilled pens, a specialty medication used to treat certain medical conditions. The contract has a firm fixed price pricing type and an ultimate completion date of July 19, 2024. AmerisourceBergen holds a significant Indefinite...
- This federal contract award, valued at $16,313.79, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for the supply of Skyrizi 150 mg/ml pen injector, a medication used for the treatment of various medical conditions. The contract has an ultimate completion date of March 5, 2025 and is a Firm Fixed Price (FFP) agreement. It is not designated as a set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,121.07 firm fixed-price delivery order is for the supply of Skyrizi 150 mg/ml syringes. The contract has an ultimate completion date of January 6, 2025 and was awarded on January 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,720.89 firm fixed price delivery order is for the supply of Skyrizi 150 mg/ml pens, a medication used to treat certain medical conditions. The contract has an ultimate completion date of October 31, 2022 and was awarded on October 28, 2022. This award is associated with a larger $999,999,999 Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $46,765.40, is for the delivery of SKYRIZI 150 MG/ML PENML, a medical product, with an ultimate completion date of April 8, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the provision of medical products, including Skyrizi 150 mg/ml pens, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has a ceiling value of $12,939.51 and is a firm fixed price delivery order, with an ultimate completion date of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,456.34, is a delivery order for the supply of SKYRIZI 150 MG/ML PENML, a pharmaceutical product. The contract has an ultimate completion date of December 10, 2024 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
- This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,827.51 firm-fixed-price contract is for the delivery of the specialty medication Skyrizi 150 mg/ml pens, with a performance period through September 2024. The award is not designated under any set-aside program, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FLZYCDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,460.62, is for the delivery of Skyrizi 150 mg/ml prefilled pens, a specialty medication used to treat certain medical conditions. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of October 8, 2024. The award was made on October 7, 2024, and the contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.5k | 10/7/24 |